IAC, Liberty reach agreement over IAC spin-offs

June 14 (Reuters) - BioVeris Corp. BIOV.O said proxy advisory firm Institutional Shareholder Services Inc. recommended that shareholders vote for the pending acquisition of BioVeris by Roche (ROG.VX).

Earlier this week, another proxy advisory firm Glass Lewis & Co. also recommended that BioVeris shareholders vote for the merger, the company said in a statment.

BioVeris agreed to be acquired by Roche for about $600 million in cash, or $21.50 per share.

(Reporting by Jennifer Robin Raj in Bangalore)

((Editing by Deepak Kannan; Reuters Messaging: aruna.jennifer.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: BIOVERIS ISS/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3975